Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lorand

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Genomics|December 14, 2020
Robust ΔΔct estimateArun Kumar, Daniel Lorand
Statistics in Medicine|March 27, 2015
A practical design for a dual-agent dose-escalation trial that incorporates pharmacokinetic dataAmy Cotterill, Daniel Lorand, Jixian Wang, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2006
Effect of various diuretic treatments on rosiglitazone-induced fluid retentionJanaka Karalliedde, Robin Buckingham, Margaret Starkie, et al.
Eye (London, England)|May 6, 2022
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysisUrsula Schmidt-Erfurth, Zufar Mulyukov, Bianca S Gerendas, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 25, 2021
A framework to guide dose & regimen strategy for clinical drug developmentOliver Sander, Baldur Magnusson, Inga Ludwig, et al.
The British Journal of Ophthalmology|August 7, 2021
Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL studyFrank G Holz, Rodrigo Abreu-Gonzalez, Francesco Bandello, et al.
Ophthalmology Science|September 10, 2024
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility StudyZufar Mulyukov, Pearse A Keane, Jayashree Sahni, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Genomics|December 14, 2020
Robust ΔΔct estimateArun Kumar, Daniel Lorand
Statistics in Medicine|March 27, 2015
A practical design for a dual-agent dose-escalation trial that incorporates pharmacokinetic dataAmy Cotterill, Daniel Lorand, Jixian Wang, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2006
Effect of various diuretic treatments on rosiglitazone-induced fluid retentionJanaka Karalliedde, Robin Buckingham, Margaret Starkie, et al.
Eye (London, England)|May 6, 2022
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysisUrsula Schmidt-Erfurth, Zufar Mulyukov, Bianca S Gerendas, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 25, 2021
A framework to guide dose & regimen strategy for clinical drug developmentOliver Sander, Baldur Magnusson, Inga Ludwig, et al.
The British Journal of Ophthalmology|August 7, 2021
Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL studyFrank G Holz, Rodrigo Abreu-Gonzalez, Francesco Bandello, et al.
Ophthalmology Science|September 10, 2024
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility StudyZufar Mulyukov, Pearse A Keane, Jayashree Sahni, et al.
Pageof 1